期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
急性ST段抬高型心肌梗死冠脉介入患者再灌注延迟及影响因素 被引量:1
1
作者 魏欣 《河南医学研究》 CAS 2021年第9期1627-1629,共3页
目的探讨急性ST段抬高型心肌梗死(STEMI)经皮冠状动脉介入(PCI)患者再灌注延迟及其影响因素。方法选择2019年5月至2020年5月在潢川县人民医院行PCI的140例STEMI患者,将发生再灌注延迟的患者纳入延迟组,未发生再灌注延迟的患者纳入未延... 目的探讨急性ST段抬高型心肌梗死(STEMI)经皮冠状动脉介入(PCI)患者再灌注延迟及其影响因素。方法选择2019年5月至2020年5月在潢川县人民医院行PCI的140例STEMI患者,将发生再灌注延迟的患者纳入延迟组,未发生再灌注延迟的患者纳入未延迟组。对两组患者的一般资料进行比较,分析患者再灌注延迟的影响因素。结果140例STEMI患者PCI再灌注延迟98例,占70.00%,平均首次医疗接触至球囊扩张(FMC-B)时间为(118.20±12.74)min;未发生再灌注延迟42例,占30.00%,平均FMC-B时间为(82.43±7.08)min。两组FMC-B时间比较,差异有统计学意义(P<0.05)。单因素分析和多因素logistic回归分析发现,年龄≥60岁、女性、非120现场接送、居住地为乡村是导致STEMI PCI治疗患者再灌注延迟的危险因素(P<0.05)。结论年龄≥60岁、女性、非120现场接送、居住地为乡村均可能增加STEMI患者再灌注延迟风险,应针对上述危险因素积极改进急诊体系与流程,尽可能缩短FMC-B时间,以改善患者预后。 展开更多
关键词 急性ST段抬高型心肌梗死 经皮冠状动脉介入 再灌注延迟 影响因素
在线阅读 下载PDF
Patients with ST-segment elevation of myocardial infarction miss out on early reperfusion: when to undergo delayed revascularization 被引量:5
2
作者 Wen ZHENG Cheuk-Man YU +6 位作者 Jing LIU Wu-Xiang XIE Miao WANG Yu-Jiao ZHANG Jian SUN Shao-Ping NIE Dong ZHAO 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2017年第8期524-531,共8页
Objective There are still a high proportion of patients with ST-segment elevation myocardial infarction (STEMI) missing out early reperfusion even in the primary percutaneous coronary intervention (PCI) era. Most ... Objective There are still a high proportion of patients with ST-segment elevation myocardial infarction (STEMI) missing out early reperfusion even in the primary percutaneous coronary intervention (PCI) era. Most of them are stable latecomers, but the optimal time to undergo delayed PCI for stable ones remains controversial. Methods We investigated all STEMI patients who underwent delayed PCI (2-28 days after STEMI) during 2007-2010 in Beijing and excluded patients with hemodynamic instability. The primary outcome was maj or adverse cardiovascular events (MACEs). Results This study finally enrolled 5,417 STEMI patients and assigned them into three groups according to individual delayed time (Early group, 55.9%; Medium group, 35.4%; Late group, 8.7%). During 1-year follow-up, MACEs occurred in 319 patients. The incidence of MACEs were respectively 7.1%, 5.6% and 6.7% among three groups. The Medium group had less recurrent myocardial infarction plus cardiac death (hazard ratio, 0.525; 95% confidence interval, 0.294-0.938, P = 0.030) than Late group and less repeat revascularization (hazard ratio, 0.640; 95% confidence interval, 0.463-0.883, P = 0.007) than Early group in pairwise comparisons. We depicted the incidence of major adverse cardiovascular event (MACE) by delayed time as a quadratic curve and found the bottom appeared at day 14. Conclusions The delayed PCI time varied in the real-world practice, but undergoing operations on the second week after STEMI had greater survival benefit and less adverse events for whom without early reperfusion and hemodynamic instability. 展开更多
关键词 ANGIOPLASTY EPIDEMIOLOGY Latecomer Myocardial infarction STENTS
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部